Home / Blog / Match Prescriptions to a 2027 ACA Plan Formulary

How to Match Your Prescriptions to a 2027 ACA Marketplace Plan Formulary During November 2026 Open Enrollment

By HealthCalc Team

Published November 2, 2026

12 min read

Open Enrollment for 2027 ACA Marketplace plans opened Sunday, November 1, 2026. The first weekend tells you a lot: the premium shock is real for households that lost the enhanced subsidies, provider directories are already drawing scrutiny, and a quieter problem is already costing people real money — a formulary mismatch between the plan they are leaning toward and the prescriptions they actually take.

A formulary mismatch rarely surfaces during enrollment. It surfaces in the second week of January, at a pharmacy counter, when a $35 copay becomes $410, when a daily medication is excluded with no warning, or when a prior authorization form the prescriber has to fill out produces a two-week gap in refills. By then the Open Enrollment window has shrunk, the ability to switch plans is capped, and the simplest fix — picking a different plan — is harder to execute.

This guide covers how formularies change year to year, how to pull every active prescription into a verifiable list, the step-by-step protocol to check each drug against a 2027 ACA plan on HealthCare.gov, how to read tier placement and utilization management flags, the five warning signs that a plan is a poor match for your medications, and the three overlapping fallbacks (therapeutic alternative, formulary exception, manufacturer assistance) when a drug is excluded or on a bad tier.

What a Formulary Match Actually Means

A formulary is the list of prescription drugs an ACA plan agrees to cover for a plan year. Each drug sits on a cost tier that determines what you pay at the pharmacy, and most tiers above the first carry one or more utilization management flags that attach conditions to coverage.

TierTypical drug typeTypical cost share
Tier 1Preferred generic$0 to $15 copay
Tier 2Non-preferred generic or preferred brand$25 to $60 copay
Tier 3Non-preferred brand$60 to $120 copay, or 20 to 30% coinsurance
Tier 4Specialty — high-cost brand or biologic25 to 40% coinsurance, often with monthly cap
Tier 5 or 6Preferred or non-preferred specialty30 to 50% coinsurance up to the OOP max

A real match is not just "my drug is on the formulary." It is a three-part check: the drug is on the 2027 formulary at all, it sits on a tier whose cost is sustainable for a full year, and the utilization management conditions attached to it (prior authorization, step therapy, quantity limits) are ones you can realistically clear. A drug on Tier 2 with a prior authorization that your prescriber routinely gets approved in two days is a real match. The same drug on Tier 2 with a step therapy requirement you have already failed under your current plan is not.

Why the Formulary Is a New Document Every January

Carriers rebuild formularies every year, and the rebuilt list rarely matches the one you had in 2026. Three things change in predictable ways.

Tier placement rotates with manufacturer rebate negotiations. Preferred-brand status on Tier 2 is a commercial negotiation between the carrier's pharmacy benefit manager and the drug maker, and it is renegotiated annually. A drug that was Tier 2 in 2026 can move to Tier 3 in 2027 on the same plan because the rebate deal changed. The clinical effectiveness of the drug has not changed; the price your plan agreed to pay for it has.

Utilization management rules tighten most years. Carriers add prior authorization and step therapy requirements to control cost, especially on drug classes where generic alternatives exist. Through 2024 to 2026, that pressure has concentrated most heavily on GLP-1 medications (Ozempic, Wegovy, Zepbound, Mounjaro), specialty biologics for inflammatory conditions, newer migraine preventives, and attention medications. The 2027 formularies published to HealthCare.gov in late October 2026 show the same pattern.

Exclusions appear with little notice. A drug on the 2026 formulary can be absent from the 2027 formulary entirely, with the only notice being a form Annual Notice of Change letter mailed in September or October. Enrollees who auto-reenroll into the "same" plan on December 15 are frequently surprised to discover the plan name is the same but the formulary is not.

Related reading on auto-reenrollment: How to Stop Unwanted ACA Auto-Reenrollment for 2027 →

Build the Prescription List Before You Open HealthCare.gov

The verification is only as reliable as the list you start with. Spend twenty minutes assembling a complete inventory of every prescription anyone in the household takes before you touch the Marketplace. Partial lists produce partial matches.

  1. Open your current pharmacy's app or website and pull the twelve-month refill history for every family member on the plan.
  2. Add any prescription filled through a different pharmacy, mail order, or a specialty pharmacy (a common gap: specialty biologics shipped directly from the plan's specialty pharmacy are not in the retail pharmacy's history).
  3. Add occasional prescriptions filled fewer than once per quarter: migraine abortives, controller inhalers, ADHD stimulants on an as-needed schedule, hormonal cycle medications, allergy rescue inhalers, antivirals, antibiotics with recurring refills.
  4. For each drug, record: brand name, generic name, strength, directions (daily, as needed), and the current tier and copay on your 2026 plan if you have it.
  5. Flag any drug you know has given you prior authorization or step therapy trouble under any plan in the last three years. These are the ones most likely to produce a formulary mismatch in 2027.

The list should fit on one page. Twenty-eight drugs is unusual; six to twelve is typical for a two-adult household. The list is the input to every subsequent step.

The Step-by-Step Verification Protocol on HealthCare.gov

Run this on your top two or three 2027 plan candidates. Expect fifteen minutes per plan the first time, five on the second plan once you know the flow.

1Open the plan details page in Window Shopping or your application

From the plan results in Window Shopping, click on the plan name to open its details. Each 2027 Marketplace plan is required to publish a Summary of Benefits and Coverage and link to the plan's full formulary document and online drug lookup. Capture the exact plan name and HIOS plan ID; you will need both if you call the carrier later.

Window Shopping walkthrough: how to find the HIOS ID →

2Use the plan's online drug lookup, not Google

Click the formulary drug lookup link on the plan details page. Enter each drug on your list by brand or generic name. The tool returns the tier, utilization management flags, and preferred-pharmacy indicator for that specific plan and plan year. A Google search for "Humira formulary tier Anthem" can show you results from the wrong plan, the wrong year, or a different carrier entirely. The plan's own 2027 lookup is the only authoritative source.

3Record four pieces of information per drug

For every drug on your list, record: whether it is on the 2027 formulary, the tier number, the utilization management flags (PA for prior authorization, ST for step therapy, QL for quantity limits), and whether a preferred-pharmacy requirement would force you to switch pharmacies. Save a screenshot per drug with the plan ID visible, dated for your records.

4Translate tiers into dollars

Click back to the plan's Summary of Benefits and Coverage and find the prescription drug cost-sharing table. It will show the copay or coinsurance for each tier, before and after the deductible, for retail and mail-order fills. Multiply each drug's monthly cost by twelve, apply the coinsurance if any, and add it to a running total. For specialty drugs on coinsurance, the total is often capped at the OOP maximum — include a check for whether your projected drug cost alone would push you to the cap.

5Compare the projected drug cost against the premium savings

Add the projected annual drug cost from Step 4 to the net annual premium (after APTC subsidy) for the plan. Do this for your top two or three plan candidates. The lowest-premium plan is almost never the lowest total cost if any family member takes a brand or specialty medication.

Total time for a six-to-twelve drug household on two or three candidate plans: thirty to fifty minutes, with the actual plan commitment the final decision. The alternative is the January counter-shock.

Five Warning Signs the Formulary Is a Poor Match

Warning Sign 1: A daily medication is not on the formulary at all

The clearest signal to drop the plan or request a formulary exception at enrollment. If your prescriber cannot document medical necessity and prior failures with alternatives, this plan will not work for you starting January 1.

Warning Sign 2: A daily medication is on Tier 4 or Tier 5 specialty with 30 to 50 percent coinsurance

On a brand drug priced at $1,200 per month, 40 percent coinsurance is $480 per month, or $5,760 per year, before the deductible is met. The plan may hit the OOP maximum early in the year, which can be useful for some households, but the cash-flow burden across January through March is often decisive. Check whether the plan uses a specialty copay structure (fixed dollar amount per fill) rather than coinsurance.

Warning Sign 3: Prior authorization is required for a drug you have struggled to get approved in the past

If your prescriber has had to send three rounds of medical records in prior years to get a PA approved for a specific drug, assume a new plan will require the same cycle. Ask your prescriber's office whether they have experience with the specific plan's PA process. A short answer to call the carrier's provider services line before enrollment is worth the time.

Warning Sign 4: Step therapy requires a trial you have already failed

Step therapy forces you onto a cheaper drug first; if it fails, you can move to the drug you actually need. If you have already failed the step-one drug under a different plan, the new plan may or may not accept that documentation. Call the carrier and ask: "What documentation do you accept for prior step therapy failure under a different carrier?" If the answer is vague, assume you will have to repeat the trial.

Warning Sign 5: The plan uses a copay accumulator or copay maximizer

These programs refuse to count manufacturer coupons toward your deductible or out-of-pocket maximum. For a specialty drug priced at $4,000 per month where the manufacturer provides a $12,000 annual copay card, a copay accumulator means the first three months are "free" to you via the card, but the deductible is still unmet and the OOP maximum does not advance. In April, when the card runs out, you face the full deductible as if you had never filled the drug.

Three Fallbacks When the Formulary Does Not Match

If you have found a plan that works on network and premium but fails on formulary, you have three overlapping paths before you give up on the plan.

Fallback 1: Switch to a therapeutic alternative

Ask your prescriber whether another drug in the same class, on the plan's preferred-generic or preferred-brand tier, would work for your condition. For many drug classes — statins, SSRIs, ACE inhibitors, beta blockers, PPIs — multiple options exist and the clinical difference is small. For some classes — GLP-1s, biologics, specific migraine preventives, specific stimulants — a therapeutic alternative may not be appropriate. This is a conversation with your prescriber, not a decision to make alone, and it is the single most reliable way to sidestep a formulary mismatch.

Fallback 2: Request a formulary exception

ACA plans are required to have a formulary exception process. If a therapeutic alternative is medically inappropriate — because of prior failures, contraindications, or published treatment guidelines — your prescriber can submit a formulary exception request after January 1, 2027. Documentation that typically produces an approval: a list of drugs in the class you have tried and failed with documented reasons, published clinical guidelines supporting the drug for your condition, a letter from the prescriber attesting to medical necessity. The approval, when granted, places the drug at a lower tier for the plan year.

File the exception the first week of January and expect a decision within 72 hours (24 for urgent requests). If denied, the plan is required to provide a written reason and an appeal path. Keep a copy of every submission for the appeal file.

Fallback 3: Manufacturer patient assistance

For brand and specialty drugs, most major manufacturers run patient assistance programs that reduce or eliminate out-of-pocket cost for commercially insured patients. Eligibility is typically income-based (often up to 400 or 500 percent of FPL) and requires documentation of medical necessity. Check the manufacturer's website or call their patient assistance line. This path works best when the drug has no therapeutic alternative and the formulary exception is slow or denied.

Running the Numbers With Verified Formularies

Once you have a shortlist of 2027 plans whose formularies match your prescription list, the comparison is finally honest. Use the Drug Cost Finder to estimate out-of-pocket cost for each medication under each plan's tier structure, and the ACA Subsidy Calculator to confirm net premiums after APTC. Run both for your top two plans and the one with the lower total projected cost is the one to enroll in.

Drug Cost Finder Run the ACA Subsidy Calculator Estimate Full Plan Cost
Privacy note: All calculations on this site happen in your browser. We never collect your data.

Deadline Calendar for November 2026 Through January 2027

The compressed schedule from today, November 2, 2026, through the end of Open Enrollment.

Related Guides on This Site

Bottom line: A 2027 ACA plan picked without a formulary check is a plan picked blind. Build a one-page prescription list for every household member, run the five-step verification protocol on your top two or three plans in HealthCare.gov Window Shopping, record tier and utilization management flags for every drug, and translate tiers into projected annual dollars. If a plan fails on a medication, the three fallbacks — therapeutic alternative, formulary exception, manufacturer patient assistance — stack. Decide on total projected cost (premium plus drugs plus expected utilization), not sticker premium. The hard deadline for a January 1 effective date is December 15.